Skip to main content Back to Top


Potassium Iodide and Iodine (Lugol's Solution or Strong Iodine Solution) 14 mL bottles

Reason for the Shortage

    • Safecor has Lugol's solution available.
    • The 16 ounce bottle presentations are not affected.

Available Products

    • Lugol's Solution or Strong Iodine oral solution, Safecor, Potassium Iodide 10% / Iodine 5%, 14 mL bottle, NDC 48433-0230-15

Implications for Patient Care

    • Potassium iodide and iodine is used in preparing patients for thyroidectomy, thyroid gland protection during radiopharmaceutical use, and in thyrotoxic crisis or thyroid storm.[1]
    • Potassium iodide and iodine is also approved for use as a topical antiseptic.[1-2]


    • Dosing errors have occurred with potassium iodide and iodine. Factors contributing to dosing errors include that the product is not used frequently, therefore clinicians may be unfamiliar with dosing, and because it is dosed in drops instead of mL.[2]


    1. Potassium Iodide and Iodine. Lexi-Drugs Online. Hudson, OH: Lexi-Comp Inc.; 2019.
    2. Institute for Safe Medication Practices. Look out for Lugol's...Error Prevention Strategies for This Strong Iodine Solution. Accessed September 3, 2019.


Updated December 4, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 3, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.



Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.